Fulvene-5 is a potent NADPH oxidase 4 (NOX4) inhibitor with antioxidant properties; it acts as a reactive oxygen species (ROS) modulator, an effective radioprotective agent, and exhibits antitumor activity; it reverses adaptive responses in cancer cells from pro-survival to radiosensitization and vice versa; it inhibits hemangioma growth in vivo; it downregulates the expression of Ang2, delta-like ligand 4 (DLL4), placental growth factor (PLGF), and Nrarp in a dose-dependent manner.